Rockefeller University Press

Table 1

The CD8⁺TCR Repertoire of Three HIV-infected Individuals during the Chronic Asymptomatic Stage of the Disease

TCR BV	868^*	065^*	003^‡	Controls (s.d.)^§
2	5.03^‖	4.15	6.56	5.52 (1.67)
3	2.99	3.31	2.26	4.33 (2.18)
5S2	3.62	2.00	5.67	3.25 (0.83)
6S5	2.02	2.02	3.16	1.77 (1.34)
7S1	1.93	1.00	2.24	1.59 (0.79)
8	3.59	6.86	7.65	4.48 (0.94)
9	4.04	0.71	2.16	2.16 (0.63)
12	1.71	1.54	1.75	2.24 (1.13)
13S1	5.79	12.69	4.79	1.92 (1.04)
17	3.51	6.8	4.77	6.91 (2.05)
20	2.82	4.0	2.99	1.62 (0.84)
21S3	7.44	7.02	3.76	2.44 (0.43)
22	4.96	11.21	4.27	3.1 (1.68)
23	1.59	1.59	3.27	2.79 (1.35)

TCR BV	868^*	065^*	003^‡	Controls (s.d.)^§
2	5.03^‖	4.15	6.56	5.52 (1.67)
3	2.99	3.31	2.26	4.33 (2.18)
5S2	3.62	2.00	5.67	3.25 (0.83)
6S5	2.02	2.02	3.16	1.77 (1.34)
7S1	1.93	1.00	2.24	1.59 (0.79)
8	3.59	6.86	7.65	4.48 (0.94)
9	4.04	0.71	2.16	2.16 (0.63)
12	1.71	1.54	1.75	2.24 (1.13)
13S1	5.79	12.69	4.79	1.92 (1.04)
17	3.51	6.8	4.77	6.91 (2.05)
20	2.82	4.0	2.99	1.62 (0.84)
21S3	7.44	7.02	3.76	2.44 (0.43)
22	4.96	11.21	4.27	3.1 (1.68)
23	1.59	1.59	3.27	2.79 (1.35)

Percentage of CD8⁺ T cells in 1996.

Percentage of CD8⁺ T cells in 1995.

Percentage of CD8⁺ T cells stained with mAbs specific for human TCR BV chains shown. Expansions ≥ mean + 3 SD are shown in bold.

Data from 10 HIV-uninfected controls.